Brochure: Antibody Discovery
Find out how Opto™ Plasma B Discovery using the Beacon® optofluidic system accelerates lead molecule discovery against difficult targets.
App Note: FDA-Accepted Monoclonality Assurance on the Beacon® Optofluidic System for Cell Line Development
Learn how the Beacon system’s superior cloning technology, automated imaging capabilities, and in-process quality controls provide definitive evidence of monoclonality to support regulatory approvals.
Datasheet: Opto™ Plasma B Discovery 4.0
Review workflow overview and representative results.
Product Tour: The Opto™ Plasma B Discovery 4.0 Workflow
Antibody expert, Anupam Singhal, PhD, does a 10-minute walkthrough of how the Opto™ Plasma B Discover workflow makes it possible to accelerate lead molecule discovery against difficult targets.
Webinar: A Beacon for Rapid Antibody Discovery against Difficult Targets
Panelists from Genovac, will present case studies of how they have leveraged their core genetic immunization technology and the Beacon optofluidic system to rapidly discover antibodies against challenging targets, such as GPCRs, from a variety of different animal species.
Datasheet: The Opto™ Antigen Presenting Bead Kit
Learn more about the Opto™ Antigen Presenting Bead (Opto™ APB) Kit, its key applications, and how it benefits your cell therapy development workflows by efficiently expanding more antigen-specific T cells than dendritic cells.
Application Note: Unravel the Complexity of Single Natural Killer Cell Cytotoxicity and ADCC Mediation
Explore how the Cytotoxicity Assay can be used to characterize and better understand NK cells in the pursuit of more efficacious cell therapies.
Application Note: Rapid High-Resolution Screening of Plasma B Cells to Identify Antibody Lead Candidates
Explore case studies for the rapid discovery of antibodies against challenging targets.
Brochure: Cell Therapy Development
From expanding rare, antigen-specific T cells to fully characterizing them, learn how our capabilities are making cell therapy development more efficient.
Customer Spotlight: Abveris on Antibody Discovery
Find out how Abveris is transforming their antibody discovery processes with the Beacon® optofluidic system.
Brochure: Beacon System
Discover how the Beacon system shortens timelines, simplifies workflows and reveals detailed data through deep profiling.
Poster: Antigen Validation using Berkeley Lights Opto™ Antigen Presenting Bead Kit
Explore the data from the Opto Antigen Presenting Bead Kit and its ability to relieve a critical bottleneck in the tumor antigen discovery process.
Application Note: Multidimensional Analysis of T Cell Cytotoxicity and Serial Killing Using the Opto™ Cell Therapy Development Workflow
Learn how to use multiple assays on single T cells to finally understand critical functions, such as serial killing, and how they relate to each other.
Brochure: Cell Line Development
Find out how the Opto™ CLD workflow lets you generate the best production cell lines for complex antibody therapeutics with >99% monoclonality assurance in just days.
Application Note: Identify and Select Optimal CAR T Cell Phenotypes with the Opto™ Cell Therapy Development Workflow
Learn how to combine the T Cell Proliferation Assay with either the Multiplex Cytokine Assay or Cytotoxicity Assay to find your most persistent T cells.
Customer Spotlight: Amgen on AbD and CLD
Find out how Amgen is transforming their antibody discovery and clonal cell line processes with the Berkeley Lights Platform.
Fireside Chat: Every Day Matters – Optimizing COVID-19 Therapies for Manufacturing
Dr. James Rothman, Nobel Laureate hosts an in-depth discussion with distinguished guests, Dr. Jennitte Stevens from Amgen, Dr. Gregory Bleck from Catalent-Biologics, and Dr. Trent Munro from the University of Queensland on fast-tracking the development of therapeutic antibodies and vaccines for SARS-CoV-2.
Webinar: Expand and Rapidly Validate Antigen-Specific Function of T Cells Using Fewer Cells
Yelena Bronevetsky, PhD, lays out the current challenges in tumor antigen discovery and how our Opto™ Antigen Presenting Bead Kit helps scientists overcome them.